During the past decade, Yen-Liang Kuo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yen-Liang Kuo" are "COPD" (2 trials), "Microbial Colonization" (1 trials), "Respiratory Tract Disease" (1 trials) and "Small Airway Disorders" (1 trials). Many other conditions were trialed in "Yen-Liang Kuo" in a lesser frequency.

Most popular intervention types in "Yen-Liang Kuo" are "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Partially Hydrolyzed Guar Gum (PHGG)" (1 trials) and "high flow nasal cannula and nasal cannula" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yen-Liang Kuo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yen-Liang Kuo". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yen-Liang Kuo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yen-Liang Kuo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".